Level of Evidence and Ethical Considerations for Locoregional Treatments in Metastatic Cervical Cancer—In Reply
- 1 April 2019
- journal article
- letter
- Published by American Medical Association (AMA) in JAMA Oncology
- Vol. 5 (4) , 575-576
Abstract
In Reply We are pleased by the interest of Schernberg and colleagues in our analysis of the association of definitive pelvic radiation therapy with survival amoKeywords
This publication has 5 references indexed in Scilit:
- Association of Definitive Pelvic Radiation Therapy With Survival Among Patients With Newly Diagnosed Metastatic Cervical CancerJAMA Oncology, 2018
- Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II TrialJournal of Clinical Oncology, 2018
- Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 studyThe Lancet Oncology, 2016
- Treatment outcomes of extended-field radiation therapy and the effect of concurrent chemotherapy on uterine cervical cancer with para-aortic lymph node metastasisRadiation Oncology, 2015
- A phase I/II study of extended field radiation therapy with concomitant paclitaxel and cisplatin chemotherapy in patients with cervical carcinoma metastatic to the para-aortic lymph nodes: A gynecologic oncology group studyGynecologic Oncology, 2009